Time
Theme
Speaker
8:00 - 9:00 am
Keynote
Elaine Mardis, PhD, FAACR
A Role for Genomics in Precision Diagnosis and Therapy for Pediatric Solid Tumors
Therapeutic Genomics
9:00 - 10:15 am
Kathrin Meyer, PhD, DSc
Challenges and Promises for Translation of Gene Therapy for Rare Neurological Disorders
Leslie Gordon, MD, PhD
Progeria and the Lonafarnib Journey to Approval - Lessons for Future Treatments and the Cure
Sean Ekins, PhD, DSc
Machine Learning and Generative Approaches for Rare and Neglected Disease Drug Discovery
Break
10:15 - 10:45 am
10:45 - 12:00 pm
Eneida Mendonca, MD, PhD, FAAP, FACMI, FIAHSI
Electronic Health Records as an Enabler for Precision Medicine
Emily Miraldi, PhD
Gene Regulatory Network Modeling from scRNA-sew and scATAC-seq
Karen Gripp, MD
Precision Phenotyping through an Artificial Intelligence Tool for Facial Analysis
Justin Zhan, PhD
AI-Driven Big Data Analytics
Artificial Intelligence in Genomics
Lunch
12:00 - 1:00 pm
1:00 - 2:00 pm
Keynote
John Rinn, PhD
The Role of RNA in Transcriptional Regulation
Break
2:00 - 2:30 pm
Viral Genomics
2:30 - 3:45 pm
Juan Fuxman-Bass, PhD
Virus-Host Cross-Transcriptional Regulation
Ivan Marazzi, PhD
Gene Asymmetry
Chris Benner, PhD
Deciphering the Cis-Regulatory Code Orchestrating Host Defense
Brad Rosenberg, MD, PhD
Single Cell Multiomics Characterization of the Innate Antiviral Response in Airway Epithelium
Polygenic Risk Scores
3:45 - 5:00 pm
Ingrid Holm, MD, MPH
Ethical issues and the clinical implementation of PRS
Johnathan Mosley, MD, PhD
Pragmatic Considerations for Using PRS in a Clinical Setting
Jordan Smoller, MD, ScD
Is There a Role for Polygenic Risk Scores in Psychiatry?
Iftikhar Kullo, MD
Clinical utility of polygenic risk scores for Coronary Heart Disease